Urinary cast is a useful predictor of acute kidney injury in acute heart failure. 2019

Satoshi Higuchi, and Yusuke Kabeya, and Kenichi Matsushita, and Satoko Yamasaki, and Hiroaki Ohnishi, and Hideaki Yoshino
Division of Cardiology, Department of Internal Medicine II, Kyorin University School of Medicine, Tokyo, Japan. sahiguchi-circ@umin.ac.jp.

Acute kidney injury (AKI) is associated with poor prognosis among patients with acute heart failure (AHF). Early documentation of impaired kidney function through simple examination may provide risk reduction in such patients. The present study aims to reveal an association between cellular casts and hospital-acquired AKI in AHF. This study included patients with AHF who underwent urinalysis, including urinary sediment analysis within 24 hours post admission. AKI was defined as an increase of ≥0.3 mg/dL within 48 hours or ≥1.5 times in serum creatinine level in contrast to baseline creatinine level. In this study, 114 patients with AHF (age, 75 ± 14 years; male, 59.7%) were included. Of them, 40 (35%) developed hospital-acquired AKI. Cellular casts were detected in 30 patients (26%) prior to AKI development and related to hospital-acquired AKI in the multivariate logistic regression analysis (odds ratio, 2.80; 95% confidence interval, 1.04-7.49; P = 0.041). In conclusion, cellular casts are observed occasionally in patients with AHF and potentially useful markers for development of AKI during hospitalization.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Satoshi Higuchi, and Yusuke Kabeya, and Kenichi Matsushita, and Satoko Yamasaki, and Hiroaki Ohnishi, and Hideaki Yoshino
March 2022, Kidney international reports,
Satoshi Higuchi, and Yusuke Kabeya, and Kenichi Matsushita, and Satoko Yamasaki, and Hiroaki Ohnishi, and Hideaki Yoshino
January 2008, Nephron. Clinical practice,
Satoshi Higuchi, and Yusuke Kabeya, and Kenichi Matsushita, and Satoko Yamasaki, and Hiroaki Ohnishi, and Hideaki Yoshino
January 2016, Current cardiology reviews,
Satoshi Higuchi, and Yusuke Kabeya, and Kenichi Matsushita, and Satoko Yamasaki, and Hiroaki Ohnishi, and Hideaki Yoshino
April 2020, ESC heart failure,
Satoshi Higuchi, and Yusuke Kabeya, and Kenichi Matsushita, and Satoko Yamasaki, and Hiroaki Ohnishi, and Hideaki Yoshino
October 2019, Heart failure clinics,
Satoshi Higuchi, and Yusuke Kabeya, and Kenichi Matsushita, and Satoko Yamasaki, and Hiroaki Ohnishi, and Hideaki Yoshino
July 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
Satoshi Higuchi, and Yusuke Kabeya, and Kenichi Matsushita, and Satoko Yamasaki, and Hiroaki Ohnishi, and Hideaki Yoshino
October 2022, The Veterinary record,
Satoshi Higuchi, and Yusuke Kabeya, and Kenichi Matsushita, and Satoko Yamasaki, and Hiroaki Ohnishi, and Hideaki Yoshino
March 2022, BMC nephrology,
Satoshi Higuchi, and Yusuke Kabeya, and Kenichi Matsushita, and Satoko Yamasaki, and Hiroaki Ohnishi, and Hideaki Yoshino
May 2024, BMC nephrology,
Satoshi Higuchi, and Yusuke Kabeya, and Kenichi Matsushita, and Satoko Yamasaki, and Hiroaki Ohnishi, and Hideaki Yoshino
May 2024, JCI insight,
Copied contents to your clipboard!